Common variable immunodeficiency: a new look at an old disease

The Lancet

Volumn 372, Issue 9637, 2008, Pages 489-502

  Park, Miguel A ^a   Li, James T ^a   Hagan, John B ^a   Maddox, Daniel E ^a   Abraham, Roshini S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIMALARIAL AGENT; CARBAMAZEPINE; CD19 ANTIGEN; CORTICOSTEROID; DIPHENHYDRAMINE; ETANERCEPT; FENCLOFENAC; GOLD SALT; IMMUNOGLOBULIN; INFLIXIMAB; PARACETAMOL; PENICILLAMINE; PHENYTOIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RITUXIMAB; SALAZOSULFAPYRIDINE;

ABDOMINAL CRAMP; ACUTE KIDNEY FAILURE; ALOPECIA; ANAPHYLAXIS; ANXIETY; ARTHRALGIA; ASEPTIC MENINGITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; CHILL; CLINICAL PRACTICE; COLD SWEAT; COMMON VARIABLE IMMUNODEFICIENCY; CROHN DISEASE; DEEP VEIN THROMBOSIS; DIFFERENTIAL DIAGNOSIS; EDUCATION PROGRAM; FEVER; FLUSHING; GASTROINTESTINAL DISEASE; GENETIC DISORDER; GRANULOMATOSIS; HEADACHE; HEALTH CARE; HEALTH SURVEY; HEART INFARCTION; HUMAN; IMMUNOGLOBULIN DEFICIENCY; INCIDENCE; INFECTION; INJECTION SITE INFLAMMATION; LEUKOPENIA; LUNG EMBOLISM; LUNG INFECTION; MALAISE; MORBIDITY; MORTALITY; MYALGIA; NAUSEA; NEOPLASM; PHENOTYPE; POPULATION; PREVALENCE; PRIORITY JOURNAL; RASH; REVIEW; SIDE EFFECT; STROKE; THROMBOTIC THROMBOCYTOPENIC PURPURA; VACCINATION;

EID: 48649085583     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61199-X     Document Type: Review

References (132)

1. Cunningham-Rundles C. Common variable immunodeficiency. Curr Allergy Asthma Rep 1 (2001) 421-429
2. Hermaszewski R.A., and Webster A.D. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med 86 (1993) 31-42
3. Winkelstein J.A., Marino M.C., Johnston Jr. R.B., et al. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine (Baltimore) 79 (2000) 155-169
4. Cunningham-Rundles C. Immune deficiency: office evaluation and treatment. Allergy Asthma Proc 24 (2003) 409-415
5. Janeway C.A., Apt L., and Gitlin D. Agammaglobulinemia. Trans Assoc Am Physicians 66 (1953) 200-202
6. Schroeder Jr. H.W. Genetics of IgA deficiency and common variable immunodeficiency. Clin Rev Allergy Immunol 19 (2000) 127-140
7. Eades-Perner A.M., Gathmann B., Knerr V., et al. The European internet-based patient and research database for primary immunodeficiencies: results 2004-06. Clin Exp Immunol 147 (2007) 306-312
8. Bonilla F.A., Bernstein I.L., Khan D.A., et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 94 5 suppl 1 (2005) S1-S63
9. Fasth A. Primary immunodeficiency disorders in Sweden: cases among children, 1974-1979. J Clin Immunol 2 (1982) 86-92
10. McCluskey D.R. Prevalence of primary hypogammaglobulinemia in Northern Ireland. Proc R Coll Physicians Edinb 19 (1989) 191-194
11. Hammarstrom L., Vorechovsky I., and Webster D. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 120 (2000) 225-231
12. Schroeder Jr. H.W., Schroeder III H.W., and Sheikh S.M. The complex genetics of common variable immunodeficiency. J Investig Med 52 (2004) 90-103
13. Vorechovsky I., Cullen M., Carrington M., Hammarstrom L., and Webster A.D. Fine mapping of IGAD1 in IgA deficiency and common variable immunodeficiency: identification and characterization of haplotypes shared by affected members of 101 multiple-case families. J Immunol 164 (2000) 4408-4416
14. Vorechovsky I., Zetterquist H., Paganelli R., et al. Family and linkage study of selective IgA deficiency and common variable immunodeficiency. Clin Immunol Immunopathol 77 (1995) 185-192
15. Cunningham-Rundles C., and Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92 (1999) 34-48
16. Hermans P.E., Diaz-Buxo J.A., and Stobo J.D. Idiopathic late-onset immunoglobulin deficiency: clinical observations in 50 patients. Am J Med 61 (1976) 221-237
17. Ogershok P.R., Hogan M.B., Welch J.E., Corder W.T., and Wilson N.W. Spectrum of illness in pediatric common variable immunodeficiency. Ann Allergy Asthma Immunol 97 (2006) 653-656
18. Conley M.E., Notarangelo L.D., and Etzioni A. Diagnostic criteria for primary immunodeficiencies: representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 93 (1999) 190-197
19. Tsuiji M., Yurasov S., Velinzon K., Thomas S., Nussenzweig M.C., and Wardemann H. A checkpoint for autoreactivity in human IgM+ memory B cell development. J Exp Med 203 (2006) 393-400
20. Brandt D., and Gershwin M.E. Common variable immune deficiency and autoimmunity. Autoimmun Rev 5 (2006) 465-470
21. Cunningham-Rundles C. Hematologic complications of primary immune deficiencies. Blood Rev 16 (2002) 61-64
22. Michel M., Chanet V., Galicier L., et al. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine (Baltimore) 83 (2004) 254-263
23. Di Renzo M., Pasqui A.L., and Auteri A. Common variable immunodeficiency: a review. Clin Exp Med 3 (2004) 211-217
24. Horn J., Thon V., Bartonkova D., et al. Anti-IgA antibodies in common variable immunodeficiency (CVID): diagnostic workup and therapeutic strategy. Clin Immunol 122 (2007) 156-162
25. Knight A.K., and Cunningham-Rundles C. Inflammatory and autoimmune complications of common variable immune deficiency. Autoimmun Rev 5 (2006) 156-159
26. Scharenberg A.M., Hannibal M.C., Torgerson T.R., Ochs H.D., and Rawlings D.J. Common variable immunodeficiency overview. Gene Reviews (2006). http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=gene.chapter.cvid (accessed March 12, 2008).
27. Tanaka N., Kim J.S., Bates C.A., et al. Lung diseases in patients with common variable immunodeficiency: chest radiographic, and computed tomographic findings. J Comput Assist Tomogr 30 (2006) 828-838
28. Kainulainen L., Varpula M., Liippo K., Svedstrom E., Nikoskelainen J., and Ruuskanen O. Pulmonary abnormalities in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol 104 (1999) 1031-1036
29. Curtin J.J., Webster A.D., Farrant J., and Katz D. Bronchiectasis in hypogammaglobulinaemia-a computed tomography assessment. Clin Radiol 44 (1991) 82-84
30. Obregon R.G., Lynch D.A., Kaske T., Newell Jr. J.D., and Kirkpatrick C.H. Radiologic findings of adult primary immunodeficiency disorders. Contribution of CT. Chest 106 (1994) 490-495
31. García M.M., de Rojas M.D., Manzur M.N., et al. Respiratory disorders in common variable immunodeficiency. Respir Med 95 (2001) 191-195
32. Morimoto Y., and Routes J.M. Granulomatous disease in common variable immunodeficiency. Curr Allergy Asthma Rep 5 (2005) 370-375
33. Bates C.A., Ellison M.C., Lynch D.A., Cool C.D., Brown K.K., and Routes J.M. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol 114 (2004) 415-421
34. Mechanic L.J., Dikman S., and Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Ann Intern Med 127 (1997) 613-617
35. Wehr C., Kivioja T., Schmitt C., et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 11 (2007) 77-85
36. Fasano M.B., Sullivan K.E., Sarpong S.B., et al. Sarcoidosis and common variable immunodeficiency: report of 8 cases and review of the literature. Medicine 75 (1996) 251-261
37. Wheat W.H., Cool C.D., Morimoto Y., et al. Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency. J Exp Med 202 (2005) 479-484
38. Cataldo F., Marino V., Ventura A., Bottaro G., and Corazza G.R. Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: an Italian multicentre study. Gut 42 (1998) 362-365
39. Klemola T. Deficiency of immunoglobulin A. Ann Clin Res 19 (1987) 248-257
40. Kinlen L.J., Webster A.D., Bird A.G., et al. Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet 1 (1985) 263-266
41. Mellemkjaer L., Hammarstrom L., Andersen V., et al. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol 130 (2002) 495-500
42. Vorechovsky I., Scott D., Haeney M.R., and Webster D.A. Chromosomal radiosensitivity in common variable immune deficiency. Mutat Res 290 (1993) 255-264
43. Jaffe E.F., Lejtenyi M.C., Noya F.J.D., and Mazer B.D. Secondary hypogammaglobulinemia. Immunol Allergy Clin North Am 21 (2001) 1-17
44. Hamilos D.L., Young R.M., Peter J.B., Agopian M.S., Ikle D.N., and Barka N. Hypogammaglobulinemia in asthmatic patients. Ann Allergy 68 (1992) 472-481
45. Lack G., Ochs H.D., and Gelfand E.W. Humoral immunity in steroid-dependent children with asthma and hypogammaglobulinemia. J Pediatr 129 (1996) 898-903
46. Conley M.E., and Howard V. Clinical findings leading to the diagnosis of X-linked agammaglobulinemia. J Pediatr 141 (2002) 566-571
47. Eastwood D., Gilmour K.C., Nistala K., et al. Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency. Clin Exp Immunol 137 (2004) 584-588
48. Weston S.A., Prasad M.L., Mullighan C.G., Chapel H., and Benson E.M. Assessment of male CVID patients for mutations in the Btk gene: how many have been misdiagnosed?. Clin Exp Immunol 124 (2001) 465-469
49. Bossuyt X., Moens L., Van Hoeyveld E., et al. Coexistence of (partial) immune defects and risk of recurrent respiratory infections. Clin Chem 53 (2007) 124-130
50. Alachkar H., Taubenheim N., Haeney M.R., Durandy A., and Arkwright P.D. Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency. Clin Immunol 120 (2006) 310-318
51. Buckley R.H. Primary immunodeficiency or not? Making the correct diagnosis. J Allergy Clin Immunol 117 (2006) 756-758
52. Eisenstein E.M., Jaffe J.S., and Strober W. Reduced interleukin-2 (IL-2) production in common variable immunodeficiency is due to a primary abnormality of CD4+ T cell differentiation. J Clin Immunol 13 (1993) 247-258
53. Jaffe J.S., Eisenstein E., Sneller M.C., and Strober W. T-cell abnormalities in common variable immunodeficiency. Pediatr Res 33 1 suppl (1993) S24-S27
54. Jaffe J.S., Strober W., and Sneller M.C. Functional abnormalities of CD8+ T cells define a unique subset of patients with common variable immunodeficiency. Blood 82 (1993) 192-201
55. Baumert E., Wolff-Vorbeck G., Schlesier M., and Peter H.H. Immunophenotypical alterations in a subset of patients with common variable immunodeficiency (CVID). Clin Exp Immunol 90 (1992) 25-30
56. Holm A.M., Sivertsen E.A., Tunheim S.H., et al. Gene expression analysis of peripheral T cells in a subgroup of common variable immunodeficiency shows predominance of CCR7(-) effector-memory T cells. Clin Exp Immunol 138 (2004) 278-289
57. Aspalter R.M., Sewell W.A., Dolman K., Farrant J., and Webster A.D. Deficiency in circulating natural killer (NK) cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia. Clin Exp Immunol 121 (2000) 506-514
58. Bayry J., Hermine O., Webster D.A., Levy Y., and Kaveri S.V. Common variable immunodeficiency: the immune system in chaos. Trends Mol Med 11 (2005) 370-376
59. Brouet J.C., Chedeville A., Fermand J.P., and Royer B. Study of the B cell memory compartment in common variable immunodeficiency. Eur J Immunol 30 (2000) 2516-2520
60. Goldacker S., and Warnatz K. Tackling the heterogeneity of CVID. Curr Opin Allergy Clin Immunol 5 (2005) 504-509
61. Moratto D., Gulino A.V., Fontana S., et al. Combined decrease of defined B and T cell subsets in a group of common variable immunodeficiency patients. Clin Immunol 121 (2006) 203-214
62. Taubenheim N., von Hornung M., Durandy A., et al. Defined blocks in terminal plasma cell differentiation of common variable immunodeficiency patients. J Immunol 175 (2005) 5498-5503
63. Cunningham-Rundles C. Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immunol 9 (1989) 22-33
64. Eibl M.M., and Wolf H.M. Common variable immunodeficiency: clinical aspects and recent progress in identifying the immunological defect(s). Folia Microbiol 40 (1995) 360-366
65. Cunningham-Rundles C., Bodian C., Ochs H.D., Martin S., Reiter-Wong M., and Zhuo Z. Long-term low-dose IL-2 enhances immune function in common variable immunodeficiency. Clin Immunol 100 (2001) 181-190
66. Punnonen J., Kainulainen L., Ruuskanen O., Nikoskelainen J., and Arvilommi H. IL-4 synergizes with IL-10 and anti-CD40 MoAbs to induce B-cell differentiation in patients with common variable immunodeficiency. Scand J Immunol 45 (1997) 203-212
67. Reinherz E.L., Geha R., Wohl M.E., Morimoto C., Rosen F.S., and Schlossman S.F. Immunodeficiency associated with loss of T4+ inducer T-cell function. N Engl J Med 304 (1981) 811-816
68. Boncristiano M., Majolini M.B., D'Elios M.M., et al. Defective recruitment and activation of ZAP-70 in common variable immunodeficiency patients with T cell defects. Eur J Immunol 30 (2000) 2632-2638
69. Majolini M.B., D'Elios M.M., Boncristiano M., et al. Uncoupling of T-cell antigen receptor and downstream protein tyrosine kinases in common variable immunodeficiency. Clin Immunol Immunopathol 84 (1997) 98-102
70. Farrington M., Grosmaire L.S., Nonoyama S., et al. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci USA 91 (1994) 1099-1103
71. North M.E., Webster A.D., and Farrant J. Primary defect in CD8+ lymphocytes in the antibody deficiency disease (common variable immunodeficiency): abnormalities in intracellular production of interferon-gamma (IFN-gamma) in CD28+ ('cytotoxic') and CD28- ('suppressor') CD8+ subsets. Clin Exp Immunol 111 (1998) 70-75
72. Tangye S.G., Liu Y.J., Aversa G., Phillips J.H., and de Vries J.E. Identification of functional human splenic memory B cells by expression of CD148 and CD27. J Exp Med 188 (1998) 1691-1703
73. Piqueras B., Lavenu-Bombled C., Galicier L., et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 23 (2003) 385-400
74. Warnatz K., Denz A., Drager R., et al. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99 (2002) 1544-1551
75. Durandy A., Peron S., and Fischer A. Hyper-IgM syndromes. Curr Opin Rheumatol 18 (2006) 369-376
76. Lee W.I., Torgerson T.R., Schumacher M.J., Yel L., Zhu Q., and Ochs H.D. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood 105 (2005) 1881-1890
77. Agematsu K., Nagumo H., Yang F.C., et al. B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production. Eur J Immunol 27 (1997) 2073-2079
78. Fecteau J.F., Cote G., and Neron S. A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J Immunol 177 (2006) 3728-3736
79. Klein U., Kuppers R., and Rajewsky K. Human IgM+IgD+ B cells, the major B cell subset in the peripheral blood, express V kappa genes with no or little somatic mutation throughout life. Eur J Immunol 23 (1993) 3272-3277
80. Klein U., Kuppers R., and Rajewsky K. Evidence for a large compartment of IgM-expressing memory B cells in humans. Blood 89 (1997) 1288-1298
81. Weller S., Braun M.C., Tan B.K., et al. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 104 (2004) 3647-3654
82. Weller S., Faili A., Garcia C., et al. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc Natl Acad Sci USA 98 (2001) 1166-1170
83. Tangye S.G., and Good K.L. Human IgM+CD27+ B cells: memory B cells or "memory" B cells?. J Immunol 179 (2007) 13-19
84. Carsetti R., Rosado M.M., Donnanno S., et al. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol 115 (2005) 412-417
85. Ferry B.L., Jones J., Bateman E.A., et al. Measurement of peripheral B cell subpopulations in common variable immunodeficiency (CVID) using a whole blood method. Clin Exp Immunol 140 (2005) 532-539
86. Grimbacher B., Hutloff A., Schlesier M., et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 4 (2003) 261-268
87. Salzer U., Maul-Pavicic A., Cunningham-Rundles C., et al. ICOS deficiency in patients with common variable immunodeficiency. Clin Immunol 113 (2004) 234-240
88. Castigli E., Wilson S., Garibyan L., et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 39 (2007) 430-431
89. Castigli E., Wilson S.A., Garibyan L., et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 37 (2005) 829-834
90. Pan-Hammarstrom Q., Salzer U., Du L., et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 39 (2007) 429-430
91. Salzer U., Chapel H.M., Webster A.D., et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 37 (2005) 820-828
92. Warnatz K., Salzer U., and Gutenberger S. Finally found: human BAFF-R deficiency causes hypogammaglobulinemia. Clin Immunol 115 suppl 1 (2005) 820
93. van Zelm M.C., Reisli I., van der Burg M., et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 354 (2006) 1901-1912
94. Salzer U., and Grimbacher B. TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity? New genetic defects in common variable immunodeficiency. Curr Opin Allergy Clin Immunol 5 (2005) 496-503
95. Zhang L., Radigan L., Salzer U., et al. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes. J Allergy Clin Immunol 120 (2007) 1178-1185
96. Warnatz K., Bossaller L., Salzer U., et al. Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood 107 (2006) 3045-3052
97. Broides A., and Conley M.E. The role of inducible co-stimulator (ICOS) in immunodeficiency. Clin Immunol 113 (2004) 221-223
98. Greenwald R.J., Freeman G.J., and Sharpe A.H. The B7 family revisited. Annu Rev Immunol 23 (2005) 515-548
99. Mackay F., and Ambrose C. The TNF family members BAFF and APRIL: the growing complexity. Cytokine Growth Factor Rev 14 (2003) 311-324
100. Mackay F., Schneider P., Rennert P., and Browning J. BAFF and APRIL: a tutorial on B cell survival. Annu Rev Immunol 21 (2003) 231-264
101. Castigli E., and Geha R.S. Molecular basis of common variable immunodeficiency. J Allergy Clin Immunol 117 (2006) 740-746
102. Carter R.H., and Fearon D.T. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256 (1992) 105-107
103. Chanock S.J., Manolio T., Boehnke M., et al. Replicating genotype-phenotype associations. Nature 447 (2007) 655-660
104. Cunningham-Rundles C., Siegal F.P., Smithwick E.M., et al. Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease. Ann Intern Med 101 (1984) 435-439
105. Nolte M.T., Pirofsky B., Gerritz G.A., and Golding B. Intravenous immunoglobulin therapy for antibody deficiency. Clin Exp Immunol 362 (1979) 237-243
106. Roifman C.M., Lederman H.M., Lavi S., Stein L.D., Levison H., and Gelfand E.W. Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease. Am J Med 79 (1985) 171-174
107. Busse P.J., Razvi S., and Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 109 (2002) 1001-1004
108. Quartier P., Debre M., De Blic J., et al. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. J Pediatr 134 (1999) 589-596
109. Weiler C.R. Immunoglobulin therapy: history, indications, and routes of administration. Int J Dermatol 43 (2004) 163-166
110. Roifman C.M., Levison H., and Gelfand E.W. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet 1 (1987) 1075-1077
111. Chapel H.M., Spickett G.P., Ericson D., Engl W., Eibl M.M., and Bjorkander J. The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy. J Clin Immunol 20 (2000) 94-100
112. Gardulf A., Andersen V., Bjorkander J., et al. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. Lancet 345 (1995) 365-369
113. Burks A.W., Sampson H.A., and Buckley R.H. Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia: detection of IgE antibodies to IgA. N Engl J Med 314 (1986) 560-564
114. Sati H.I., Ahya R., and Watson H.G. Incidence and associations of acute renal failure complicating high-dose intravenous immunoglobulin therapy. Br J Haematol 113 (2001) 556-557
115. Caress J.B., Cartwright M.S., Donofrio P.D., and Peacock Jr. J.E. The clinical features of 16 cases of stroke associated with administration of IVIg. Neurology 60 (2003) 1822-1824
116. Stamboulis E., Theodorou V., Kilidireas K., and Apostolou T. Acute myocardial infarction following intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy in association with a monoclonal immunoglobulin G paraprotein. Eur Neurol 51 (2004) 51
117. Alliot C., Rapin J.P., Besson M., Bedjaoui F., and Messouak D. Pulmonary embolism after intravenous immunoglobulin. J R Soc Med 94 (2001) 187-188
118. Go R.S., and Call T.G. Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications. Mayo Clin Proc 75 (2000) 83-85
119. Kato E., Shindo S., Eto Y., et al. Administration of immune globulin associated with aseptic meningitis. JAMA 259 (1988) 3269-3271
120. Brennan V.M., Salome-Bentley N.J., and Chapel H.M. Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin. Clin Exp Immunol 133 (2003) 247-251
121. de Albuquerque Campos R., Sato M.N., and da Silva Duarte A.J. IgG anti-IgA subclasses in common variable immunodeficiency and association with severe adverse reactions to intravenous immunoglobulin therapy. J Clin Immunol 20 (2000) 77-82
122. Sandler S.G., Mallory D., Malamut D., and Eckrich R. IgA anaphylactic transfusion reactions. Transfus Med Rev 9 (1995) 1-8
123. Gardulf A., Nicolay U., Asensio O., et al. Rapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary immunodeficiencies-a prospective, multi-national study. J Clin Immunol 26 (2006) 177-185
124. Lindberg K., Gustafson R., Samuelson A., and Rynnel-Dagoo B. Impact of IgG replacement therapy and antibiotic treatment on the colonization of non-encapsulated Haemophilus influenzae in the nasopharynx in patients with hypogammaglobulinaemia. Scand J Infect Dis 33 (2001) 904-908
125. Sewell W.A., Buckland M., and Jolles S.R. Therapeutic strategies in common variable immunodeficiency. Drugs 63 (2003) 1359-1371
126. Nos P., Bastida G., Beltran B., Aguas M., and Ponce J. Crohn's disease in common variable immunodeficiency: treatment with antitumor necrosis factor alpha. Am J Gastroenterol 101 (2006) 2165-2166
127. Hatab A.Z., and Ballas Z.K. Caseating granulomatous disease in common variable immunodeficiency treated with infliximab. J Allergy Clin Immunology 116 (2005) 1161-1162
128. Thatayatikom A., Thatayatikom S., and White A.J. Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature. Ann Allergy Asthma Immunol 95 (2005) 293-300
129. Carbone J., Escudero A., Mayayo M., et al. Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency. Ann N Y Acad Sci 1051 (2005) 666-671
130. Wakim M., Shah A., Arndt P.A., et al. Successful anti-CD20 monoclonal antibody treatment of severe autoimmune hemolytic anemia due to warm reactive IgM autoantibody in a child with common variable immunodeficiency. Am J Hematol 76 (2004) 152-155
131. Smith K.J., and Skelton H. Common variable immunodeficiency treated with a recombinant human IgG, tumour necrosis factor-alpha receptor fusion protein. Br J Dermatol 144 (2001) 597-600
132. Atkinson W.L., Pickering L.K., Schwartz B., et al. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR Recomm Rep 51 (2002) 1-35